Pharma

Kirkland & Ellis Amplifies Philadelphia Presence with New Addition in Pharma Litigation Sector

by

Philadelphia — Kirkland & Ellis LLP is making strides in its Philadelphia office just months after establishing a presence in the city. The firm has recently welcomed a litigator focused on defending pharmaceutical and medical device companies in liability cases. This recruitment signifies the firm’s commitment to expanding its footprint in the competitive legal market. The addition of the new attorney marks a strategic move to bolster the office’s capabilities in a sector where litigation is increasingly crucial. With the growing complexity of regulations in the pharmaceutical and medical device industries, having expertise in this … Read more

Cannes Lions 2023: Celebrating Creative Brilliance with Groundbreaking Wins in Health, Pharma, and Outdoor Campaigns

by

CANNES, France — The Cannes Lions International Festival of Creativity has kicked off, showcasing groundbreaking work in various advertising sectors including health, wellness, outdoor media, and audio. This year’s festival is notable not only for its entries but also for the first-ever Grand Prix awarded to the Czech Republic. Simon Cook, CEO of LIONS, expressed excitement over the jury’s choices, highlighting the creative excellence that emerged from the 2023 submissions. “It’s exhilarating to see how creativity shapes both business landscapes and societal norms. Our jurors invested significant time and expertise to elevate the industry’s standards,” … Read more

Supreme Court Ruling Reshapes Future of Mass Tort Bankruptcy Settlements: Purdue Pharma Case Unravels Traditional Protections for Insurers

by

Washington, D.C. — In a landmark decision, the U.S. Supreme Court has issued a ruling that will reshape the landscape of bankruptcy law, particularly affecting how companies deal with mass tort liabilities through Chapter 11 bankruptcy cases. This decision notably impacts liability insurers who often resort to bankruptcy proceedings to resolve large-scale legal claims. At the center of this pivotal case is Purdue Pharma, the pharmaceutical giant behind OxyContin. This drug, marketed as a time-released painkiller, became wildly popular, turning into the most prescribed opioid in the United States. This, however, came at a steep … Read more

Law Scholar Anthony Casey’s Insights Crucial in Major Supreme Court Decision on Purdue Pharma Settlement

by

Chicago — In a landmark case, the U.S. Supreme Court recently ruled on a highly contentious bankruptcy settlement involving Purdue Pharma L.P., the maker of OxyContin, and its $6 billion proposal intended to resolve lawsuits spurred by the opioid crisis. At the heart of this legal battle was a key paragraph in the Bankruptcy Code, pivotal in determining how the courts could use bankruptcy to address mass-tort claims both swiftly and equitably. Purdue Pharma, under the ownership of the Sackler family, touched off a legal and moral storm with a proposal that included a condition … Read more